GMP Failures & Pharma Compliance – Pharma GMP

Top 10 GMP Violations Cited in USFDA Warning Letters

digi — Mon, 01 Sep 2025 22:15:00 +0000

Top 10 GMP Violations Cited in USFDA Warning Letters Most Frequent GMP Violations Highlighted in USFDA Warning Letters Introduction: Why This Topic Matters for GMP Compliance The United States Food and Drug Administration (USFDA) inspects pharmaceutical facilities worldwide to verify compliance with current Good Manufacturing Practices (cGMP). When critical deficiencies are found, the agency issues...

How to Conduct a Gap Assessment for GMP Compliance

digi — Tue, 02 Sep 2025 05:19:10 +0000

How to Conduct a Gap Assessment for GMP Compliance Step-by-Step Guide to Performing a GMP Gap Assessment Introduction: Why This Topic Matters for GMP Compliance Pharmaceutical manufacturers face continuous pressure to demonstrate compliance with Good Manufacturing Practices (GMP) as outlined by regulators such as the USFDA, EMA, WHO, and PIC/S. A GMP gap assessment is...

Real-Life Case Studies of GMP Failure in Indian Pharma

digi — Tue, 02 Sep 2025 13:11:44 +0000

Real-Life Case Studies of GMP Failure in Indian Pharma Case Studies Highlighting GMP Failures in Indian Pharmaceutical Companies Introduction: Why This Topic Matters for GMP Compliance India is one of the largest global suppliers of generic medicines, accounting for a significant share of the pharmaceutical exports to regulated markets such as the United States, the...

Data Integrity Breaches That Led to Site Bans

digi — Tue, 02 Sep 2025 22:43:25 +0000

Data Integrity Breaches That Led to Site Bans How Data Integrity Breaches Resulted in Pharma Site Bans Introduction: Why This Topic Matters for GMP Compliance Data integrity is the cornerstone of Good Manufacturing Practice (GMP). Regulators such as the FDA, EMA, and WHO expect that all records—whether paper-based or electronic—accurately reflect manufacturing and testing activities....

Root Cause Analysis for GMP Non-Conformities

digi — Wed, 03 Sep 2025 06:00:35 +0000

Root Cause Analysis for GMP Non-Conformities Effective Root Cause Analysis for GMP Non-Conformities Introduction: Why This Topic Matters for GMP Compliance Non-conformities in Good Manufacturing Practice (GMP) are inevitable in complex pharmaceutical manufacturing environments. Deviations, failures, and unexpected outcomes occur despite best efforts. Regulatory bodies such as the FDA, EMA, and WHO expect that when...

Why Most Pharma Plants Fail GMP Inspections

digi — Wed, 03 Sep 2025 12:18:43 +0000

Why Most Pharma Plants Fail GMP Inspections Key Reasons Behind GMP Inspection Failures in Pharma Plants Introduction: Why This Topic Matters for GMP Compliance Pharmaceutical manufacturers operate under constant scrutiny from global regulators such as the FDA, EMA, WHO, and PIC/S. A successful GMP inspection demonstrates that a facility is capable of producing safe, effective,...

Difference Between WHO GMP, cGMP, and EU GMP

digi — Wed, 03 Sep 2025 21:59:04 +0000

Difference Between WHO GMP, cGMP, and EU GMP Comparing WHO GMP, cGMP, and EU GMP: Key Differences and Compliance Requirements Introduction: Why This Topic Matters for GMP Compliance Pharmaceutical manufacturers operate in a highly regulated global market. To supply medicines internationally, companies must demonstrate compliance with Good Manufacturing Practices (GMP) as defined by various regulatory...

Preparing for a Surprise FDA Inspection: Complete SOP

digi — Thu, 04 Sep 2025 04:07:32 +0000

Preparing for a Surprise FDA Inspection: Complete SOP Comprehensive SOP for Handling Surprise FDA Inspections Introduction: Why This Topic Matters for GMP Compliance FDA inspections are designed to ensure that pharmaceutical manufacturers consistently comply with Good Manufacturing Practices (GMP). While some inspections are pre-announced, many are unannounced or “surprise” inspections. These inspections test a company’s...

Common GMP Issues in Tablet Manufacturing

digi — Thu, 04 Sep 2025 12:50:38 +0000

Common GMP Issues in Tablet Manufacturing Frequent GMP Challenges in Tablet Manufacturing and How to Address Them Introduction: Why This Topic Matters for GMP Compliance Tablet manufacturing, as a major component of oral solid dosage (OSD) production, is subject to strict regulatory oversight. Global agencies such as the FDA, EMA, and WHO closely examine GMP...

How to Handle a 483 Observation Without Panic

digi — Thu, 04 Sep 2025 22:11:34 +0000

How to Handle a 483 Observation Without Panic Effective Strategies to Handle FDA 483 Observations Calmly and Confidently Introduction: Why This Topic Matters for GMP Compliance During FDA inspections, investigators document potential violations of current Good Manufacturing Practice (cGMP) on Form 483. Receiving a 483 can be stressful for pharmaceutical manufacturers, but it is not...